China Raises Central R&D Budget 10% as AI, Biotech, and Gaming Sector Shifts Accelerate

The Quick Take

• China's central-level science and technology spending budget for 2026 is set 10% higher than the prior year, reinforcing government commitment to innovation leadership
• Multiple virtual cell and deep tech companies have secured funding in 2026, with the segment attracting broad investor interest
• Alibaba is reported to have sold gaming assets worth approximately $1.5 billion, continuing its portfolio rationalisation toward AI and cloud infrastructure

China's Ministry of Finance has allocated central-level science and technology spending for 2026 at 10% above the prior year's budget, underscoring the government's sustained commitment to technological self-reliance across AI, semiconductor, and biotechnology sectors. The 10% increase builds on several consecutive years of above-GDP-growth science funding increases, reflecting Beijing's strategic determination to close capability gaps with the US and achieve leadership in emerging technology domains. The spending commitment provides a fiscal floor under domestic technology companies that depend on government procurement and research grants.

The broader Chinese technology sector is experiencing a capital deployment surge across multiple segments simultaneously. Virtual cell research companies — a segment involving AI-driven cellular simulation for drug discovery — have attracted substantial venture funding in 2026, with the category reportedly seeing nearly universal fundraising success. Meanwhile, Alibaba's reported sale of gaming assets valued at approximately 100 billion yuan (around $1.5 billion) signals continued portfolio concentration on AI and cloud, consistent with the company's stated strategic priorities following its restructuring. These parallel signals point to a coherent sectoral reorientation toward deep technology.

Investors in China's technology sector should monitor the Ministry of Finance's annual budget cycle for confirmation that the 10% R&D spending trend is sustained into 2027 and beyond, as multi-year government commitment is the critical variable for domestic semiconductor and AI company revenue visibility. CXMT and SMIC production ramp milestones in advanced chip manufacturing represent the most visible indicator of whether government R&D investment is translating into commercial-scale capability, while the virtual cell sector's fundraising pipeline breadth confirms the depth of China's deep tech ambitions.

Synthesized from 3 sources.